3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Neoplasms
4
Melanoma
2
Uterine Cervical Neoplasms
1
Solid Tumor, Adult
1
Skin Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Neuromyelitis Optica
1
Neoplasms, Second Primary
1
Neoplasm Metastasis
1
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
1
Myasthenia Gravis
1
Multiple Sclerosis
1
Lung Neoplasms
1
Laryngectomy; Status
1
Hematologic Neoplasms
1
Hematologic Diseases
1
Endometrial Neoplasms
1
Encephalomyelitis, Acute Disseminated
1
Carcinoma, Renal Cell
1
COVID-19
1
Breast Neoplasms
1
Autoimmune Diseases of the Nervous System
1
Interventions
Cyclophosphamide
6
fludarabine
5
Exercise
4
Blood Specimen Collection
4
Immunotherapy, Adoptive
3
thymoglobulin
2
pegylated granulocyte colony-stimulating factor
2
Voriconazole
2
Surveys and Questionnaires
2
Stem Cell Transplantation
2
Physical Therapy Modalities
2
Parenteral Nutrition
2
Etoposide
2
Cytarabine
2
CF regimen
2
BNT162 Vaccine
2
Azacitidine
2
venetoclax
1
trihexyltetradecylphosphonium chloride
1
treosulfan
1
shengxuening
1
ruxolitinib
1
ramosetron
1
monalizumab
1
glucarpidase
1
fludarabine phosphate
1
ferrous succinate
1
eltrombopag
1
dexamethasone 21-phosphate
1
Whole-Body Irradiation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Hematologic Neoplasms
×
Data Collection
×
Clear all
NCT04776005
2024-01-03
COVIDVAC OH
Assistance Publique - Hôpitaux de Paris
Unknown
500 enrolled